We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

230 hedge funds and large institutions have $1.96B invested in Arena Pharmaceuticals Inc in 2019 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 83 increasing their positions, 58 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 25

43% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 58

7% more funds holding

Funds holding: 215 → 230 (+15)

21% less capital invested

Capital invested by funds: $2.47B → $1.96B (-$506M)

28% less call options, than puts

Call options by funds: $12M | Put options by funds: $16.7M

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
230
Holders Change
+15
Holders Change %
+6.98%
% of All Funds
5.04%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
40
Increased
83
Reduced
58
Closed
25
Calls
$12M
Puts
$16.7M
Net Calls
-$4.73M
Net Calls Change
-$7.79M

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$24.9M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$16.7M
3
State Street
State Street
Massachusetts
+$14.8M
4
Marshall Wace
Marshall Wace
United Kingdom
+$12.5M
5
APG Asset Management
APG Asset Management
Netherlands
+$12.5M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$46.5M
2
PA
Perceptive Advisors
New York
-$24M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$11.2M
4
Primecap Management
Primecap Management
California
-$8.95M
5
EMG
ETF Managers Group
New Jersey
-$8.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
First Trust Advisors
76
First Trust Advisors
Illinois
$2.93M +$3.6M +64,001 New
QI
77
QS Investors
New York
$2.91M – – –
AQR Capital Management
78
AQR Capital Management
Connecticut
$2.79M +$372K +6,618 +12%
CIP
79
Chartwell Investment Partners
Pennsylvania
$2.75M – – –
Neuberger Berman Group
80
Neuberger Berman Group
New York
$2.75M +$11.2K +200 +0.3%
Thrivent Financial for Lutherans
81
Thrivent Financial for Lutherans
Minnesota
$2.72M +$98.4K +1,751 +3%
New York State Common Retirement Fund
82
New York State Common Retirement Fund
New York
$2.71M -$181K -3,215 -5%
UBS AM
83
UBS AM
Illinois
$2.45M +$735K +13,070 +32%
Barclays
84
Barclays
United Kingdom
$2.29M -$707K -12,580 -20%
Skandinaviska Enskilda Banken (SEB)
85
Skandinaviska Enskilda Banken (SEB)
Sweden
$2.06M +$28.1K +500 +1%
State of New Jersey Common Pension Fund D
86
State of New Jersey Common Pension Fund D
New Jersey
$2.01M +$2.47M +43,900 New
SCM
87
Sio Capital Management
New York
$2.01M +$2.47M +43,857 New
Massachusetts Financial Services
88
Massachusetts Financial Services
Massachusetts
$2M +$274K +4,870 +13%
MSL
89
Mackay Shields LLC
New York
$1.77M -$95.6K -1,700 -4%
SG Americas Securities
90
SG Americas Securities
New York
$1.75M +$2.01M +35,744 +1,417%
Bank of Montreal
91
Bank of Montreal
Ontario, Canada
$1.56M +$1.68M +29,806 +712%
PNC Financial Services Group
92
PNC Financial Services Group
Pennsylvania
$1.52M +$1.87M +33,257 New
AIG
93
American International Group
New York
$1.44M -$12.4K -221 -0.7%
Manulife (Manufacturers Life Insurance)
94
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.41M +$1.74K +31 +0.1%
Legal & General Group
95
Legal & General Group
United Kingdom
$1.34M +$195K +3,468 +13%
SCP
96
Seizert Capital Partners
Michigan
$1.34M +$1.64M +29,187 New
PIM
97
Partner Investment Management
California
$1.32M +$602K +10,718 +59%
TCM
98
Tekla Capital Management
Massachusetts
$1.28M – – –
MAM
99
Martingale Asset Management
Massachusetts
$1.22M +$354K +6,305 +31%
VRS
100
Virginia Retirement Systems
Virginia
$1.21M +$56.2K +1,000 +4%
2 3
4
5 6

ARNA Hedge Fund Activity: Q3 2019 in Review

230 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2019, worth a combined $1.96B — down 21% from $2.47B a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new ARNA positions and 25 closed out — a net gain of 15 holders — while 83 added to existing stakes and 58 trimmed.

The largest buyer was PFM Health Sciences, adding an estimated $24.9M. The largest seller was Fidelity Investments, cutting an estimated $46.5M.

  • 230 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2019, up from 215 in Q2 2019.
  • Funds reported $1.96B of Arena Pharmaceuticals Inc stock for Q3 2019, down 21% quarter-over-quarter.
  • 40 funds opened new Arena Pharmaceuticals Inc positions in Q3 2019 and 25 closed out, a net change of +15 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q3 2019 was PFM Health Sciences, an estimated $24.9M added.
  • The largest Arena Pharmaceuticals Inc seller in Q3 2019 was Fidelity Investments, an estimated $46.5M sold.

Based on aggregated 13F filings for Q3 2019.